Atlas Trials

Safety and Efficacy of LibiGel® for the Treatment of Hypoactive Sexual Desire Disorder in Surgically Menopausal Women

Clinical trial NCT00613002 · COMPLETED

Trial details

NCT number
NCT00613002
Sponsor
BioSante Pharmaceuticals
Status
COMPLETED
Phase
Phase 3
Study type
INTERVENTIONAL
Hypoactive Sexual Desire Disorder
Start date
2006-12-01
Primary completion
2011-09-01
Enrollment
597

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.